Clinical Trial

Mental and Reproductive Health Integration and Access

Study acronym: MARIA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn whether an integrated package of mental health screening, brief psychosocial support, and family planning counseling delivered within routine postnatal care can improve reproductive and mental health outcomes in postpartum migrant, refugee, and underserved Jordanian women aged 15-49 attending primary health centers in Mafraq Governorate and the Al-Ghour region of Jordan. The main questions it aims to answer are: 1. Does the MARIA intervention increase the use of modern contraceptive methods among postnatal women compared to standard care? 2. Does the MARIA intervention reduce the prevalence and severity of postpartum depression symptoms compared to standard care? Researchers will compare women attending health centers that deliver the full MARIA package (integrated mental health screening, brief psychosocial support, and family planning counseling) to women attending health centers that provide standard care (routine immunization and child health services without the MARIA components) to see if the intervention improves contraceptive use and reduces postpartum depression. Participants will: * Complete a 10-question mental health screening tool (Edinburgh Postnatal Depression Scale) at their routine immunization visit * Receive a brief educational session, psychosocial support, or a referral to specialist mental health services - depending on their screening result * Receive family planning counseling and information about contraceptive options during the same visit * Be followed up by a community health worker, as needed * Participate in three interviews - one in person at enrollment and two by telephone at 4 and 7 months after joining
Trial Details
NCT Number NCT07659509
Lead Sponsor Eastern Mediterranean Public Health Network
Conditions Family Planning Services, Post Partum Depression
Enrollment 920 participants
Start Date 2026-09
Primary Completion 2027-06 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-22